Mora-Rodriguez JM, Sanchez BG, Bort A, Diaz-Yuste A, et al. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM). Life Sci 2023;336:122292.
PMID: 38030058